Clinical Trial Update: Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain Tumor [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating temozolomide plus thalidomide in patients with recurrent or progressive brain tumors has completed. The snippet does not include treatm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor

Drugs mentioned

• Temodar (Temozolomide)
• Thalomid (thalidomide)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Brain and Central Nervous System Tumors | Phase 2 | Status: COMPLETED